Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C

Saved in:
Bibliographic Details
Published in:Journal of diabetes 2018-05, Vol.10 (5), p.419-420
Main Authors: Zheng, Ying, Wang, Zhen, Xie, Zhiguo, Dai, Ruchun, Zhou, Zhiguang
Format: Article
Language:English
Subjects:
Hepatitis C
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2136-da66e13e00a291ba7f1d6f6d5bdd337b84cec3a86a1ea1f711c74ef26ed1c3f33
cites
container_end_page 420
container_issue 5
container_start_page 419
container_title Journal of diabetes
container_volume 10
creator Zheng, Ying
Wang, Zhen
Xie, Zhiguo
Dai, Ruchun
Zhou, Zhiguang
description
doi_str_mv 10.1111/1753-0407.12636
format article
fullrecord <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_proquest_journals_2023052623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2023052623</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2136-da66e13e00a291ba7f1d6f6d5bdd337b84cec3a86a1ea1f711c74ef26ed1c3f33</originalsourceid><addsrcrecordid>eNo9kEtOwzAQhi0EoqWwZocssU7xeBq7XUKhPFQJFrC2nHhCXbVpSByh7DgCV-EiHIKT0Pds5tfMpxnpY-wcRBeWdQU6xkj0hO6CVKgOWHs_OdxlHGCLnVTVVAillcJj1pIDqWINus1eRvVs7nObBx6agjhw521CgSqe2roix5OGF_Tu80BlRuUi578_f1_f0vIwodIWDfc5n1Bhgw--4sNTdpTZWUVn295hb6O71-FDNH6-fxxej6NUAqrIWaUIkISwcgCJ1Rk4lSkXJ84h6qTfSylF21cWyEKmAVLdo0wqcpBihthhl5u7Rbn4qKkKZrqoy3z50kghUcRSyRV1saXqZE7OFKWf27IxOwFLIN4An35GzX4Pwqz8mpVBs7Jp1n7N0-3NOuA_87BtYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2023052623</pqid></control><display><type>article</type><title>Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C</title><source>Wiley Online Library Open Access</source><creator>Zheng, Ying ; Wang, Zhen ; Xie, Zhiguo ; Dai, Ruchun ; Zhou, Zhiguang</creator><creatorcontrib>Zheng, Ying ; Wang, Zhen ; Xie, Zhiguo ; Dai, Ruchun ; Zhou, Zhiguang</creatorcontrib><identifier>ISSN: 1753-0393</identifier><identifier>EISSN: 1753-0407</identifier><identifier>DOI: 10.1111/1753-0407.12636</identifier><identifier>PMID: 29265717</identifier><language>eng</language><publisher>Melbourne: Wiley Publishing Asia Pty Ltd</publisher><subject>Hepatitis C</subject><ispartof>Journal of diabetes, 2018-05, Vol.10 (5), p.419-420</ispartof><rights>2017 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley &amp; Sons Australia, Ltd</rights><rights>2018 John Wiley &amp; Sons Australia, Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2136-da66e13e00a291ba7f1d6f6d5bdd337b84cec3a86a1ea1f711c74ef26ed1c3f33</citedby><orcidid>0000-0002-6401-4968</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1753-0407.12636$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1753-0407.12636$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,11544,27906,27907,46034,46458</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2F1753-0407.12636$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29265717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Ying</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Xie, Zhiguo</creatorcontrib><creatorcontrib>Dai, Ruchun</creatorcontrib><creatorcontrib>Zhou, Zhiguang</creatorcontrib><title>Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C</title><title>Journal of diabetes</title><addtitle>J Diabetes</addtitle><subject>Hepatitis C</subject><issn>1753-0393</issn><issn>1753-0407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo9kEtOwzAQhi0EoqWwZocssU7xeBq7XUKhPFQJFrC2nHhCXbVpSByh7DgCV-EiHIKT0Pds5tfMpxnpY-wcRBeWdQU6xkj0hO6CVKgOWHs_OdxlHGCLnVTVVAillcJj1pIDqWINus1eRvVs7nObBx6agjhw521CgSqe2roix5OGF_Tu80BlRuUi578_f1_f0vIwodIWDfc5n1Bhgw--4sNTdpTZWUVn295hb6O71-FDNH6-fxxej6NUAqrIWaUIkISwcgCJ1Rk4lSkXJ84h6qTfSylF21cWyEKmAVLdo0wqcpBihthhl5u7Rbn4qKkKZrqoy3z50kghUcRSyRV1saXqZE7OFKWf27IxOwFLIN4An35GzX4Pwqz8mpVBs7Jp1n7N0-3NOuA_87BtYA</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Zheng, Ying</creator><creator>Wang, Zhen</creator><creator>Xie, Zhiguo</creator><creator>Dai, Ruchun</creator><creator>Zhou, Zhiguang</creator><general>Wiley Publishing Asia Pty Ltd</general><general>John Wiley &amp; Sons, Inc</general><scope>NPM</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0002-6401-4968</orcidid></search><sort><creationdate>201805</creationdate><title>Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C</title><author>Zheng, Ying ; Wang, Zhen ; Xie, Zhiguo ; Dai, Ruchun ; Zhou, Zhiguang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2136-da66e13e00a291ba7f1d6f6d5bdd337b84cec3a86a1ea1f711c74ef26ed1c3f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Hepatitis C</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Ying</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Xie, Zhiguo</creatorcontrib><creatorcontrib>Dai, Ruchun</creatorcontrib><creatorcontrib>Zhou, Zhiguang</creatorcontrib><collection>PubMed</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Zheng, Ying</au><au>Wang, Zhen</au><au>Xie, Zhiguo</au><au>Dai, Ruchun</au><au>Zhou, Zhiguang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C</atitle><jtitle>Journal of diabetes</jtitle><addtitle>J Diabetes</addtitle><date>2018-05</date><risdate>2018</risdate><volume>10</volume><issue>5</issue><spage>419</spage><epage>420</epage><pages>419-420</pages><issn>1753-0393</issn><eissn>1753-0407</eissn><cop>Melbourne</cop><pub>Wiley Publishing Asia Pty Ltd</pub><pmid>29265717</pmid><doi>10.1111/1753-0407.12636</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-6401-4968</orcidid></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1753-0393
ispartof Journal of diabetes, 2018-05, Vol.10 (5), p.419-420
issn 1753-0393
1753-0407
language eng
recordid cdi_proquest_journals_2023052623
source Wiley Online Library Open Access
subjects Hepatitis C
title Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A56%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fulminant%20type%201%20diabetes%20caused%20by%20peginterferon%20%CE%B1%E2%80%902a%20therapy%20in%20hepatitis%20C&rft.jtitle=Journal%20of%20diabetes&rft.au=Zheng,%20Ying&rft.date=2018-05&rft.volume=10&rft.issue=5&rft.spage=419&rft.epage=420&rft.pages=419-420&rft.issn=1753-0393&rft.eissn=1753-0407&rft_id=info:doi/10.1111/1753-0407.12636&rft_dat=%3Cproquest_24P%3E2023052623%3C/proquest_24P%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2136-da66e13e00a291ba7f1d6f6d5bdd337b84cec3a86a1ea1f711c74ef26ed1c3f33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2023052623&rft_id=info:pmid/29265717&rfr_iscdi=true